A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism

被引:0
|
作者
Arlee Fafalios
Jihong Ma
Xinping Tan
John Stoops
Jianhua Luo
Marie C DeFrances
Reza Zarnegar
机构
[1] University of Pittsburgh,Department of Pathology
[2] McGowan Institute of Regenerative Medicine,undefined
[3] University of Pittsburgh,undefined
[4] University of Pittsburgh Cancer Institute,undefined
来源
Nature Medicine | 2011年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It is well regarded that insulin receptor signaling in the liver is key to proper metabolic control. Reza Zarnegar and his colleagues now show that the hepatocyte growth factor receptor, Met, physically interacts with the insulin receptor signaling complex, potentiating the latter's signaling. They also show that Met signaling restores insulin responsiveness in a mouse model of insulin resistance, suggesting a potentially new therapeutic avenue to treat prediabetes.
引用
收藏
页码:1577 / 1584
页数:7
相关论文
共 50 条
  • [41] Expression of hepatocyte growth factor (HGF) and its receptor (MET) in medullary carcinoma of the thyroid
    Mauro Papotti
    Martina Olivero
    Marco Volante
    Francesco Negro
    Maria Prat
    Paolo M. Comoglio
    Maria Flavia DiRenzo
    Endocrine Pathology, 2000, 11 : 19 - 30
  • [42] Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation
    Abella, JV
    Peschard, P
    Naujokas, MA
    Lin, T
    Saucier, C
    Urbé, S
    Park, M
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9632 - 9645
  • [43] Expression of met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors
    Scotlandi, K
    Baldini, N
    Oliviero, M
    DiRenzo, MF
    Martano, M
    Serra, M
    Manara, MC
    Comoglio, PM
    Ferracini, R
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (04): : 1209 - 1219
  • [44] Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma
    Luan, Tian
    Yu, Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12): : 5583 - 5587
  • [45] The expression of hepatocyte growth factor (HGF) and MET receptor in pancreatic ductal carcinomas (PDCs)
    Sessa, F
    Bisoni, D
    Billo, P
    Chiaravalli, AM
    Bonato, M
    Capella, C
    MODERN PATHOLOGY, 1998, 11 (01) : 156A - 156A
  • [46] Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas
    Helou, K
    Wallenius, V
    Qiu, Y
    Öhman, F
    Ståhl, F
    Klinga-Levan, K
    Kindblom, LG
    Mandahl, N
    Jansson, JO
    Levan, G
    ONCOGENE, 1999, 18 (21) : 3226 - 3234
  • [47] Ontogeny of hepatocyte growth factor and its receptor, c-met in the human placenta
    Li, XF
    Kilby, MD
    Afford, S
    Strain, A
    Ahmed, A
    Whittle, MJ
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (11): : 1165 - 1165
  • [48] Subcellular Localization of Novel Fluorescent Epidermal Growth Factor Receptor (EGFR) and Hepatocyte Growth Factor Receptor (MET) Targeted Inhibitors in Cancer Cells
    Facchin, Caterina
    Baryyan, Alaa
    Jean-Claude, Bertrand
    AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (09): : S1 - S1
  • [49] Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation
    Ljubimova, JY
    Petrovic, LM
    Arkadopoulos, N
    Blanc, P
    Geller, SA
    Demetriou, AA
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (08) : 1675 - 1680
  • [50] Lack of Hepatocyte Growth Factor Receptor (c-met) Gene Expression in Fulminant Hepatic Failure Livers Before Transplantation
    Julia Y. Ljubimova
    Lidija M. Petrovic
    Nikolaos Arkadopoulos
    Pierre Blanc
    Stephen A. Geller
    Achilles A. Demetriou
    Digestive Diseases and Sciences, 1997, 42 : 1675 - 1680